Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Sodium butyrate (NaB) in the gut of animals possesses the potential to modulate lipid metabolism, regulate innate immunity, and protect intestinal health. Accumulating data have supported the important function of metabolites of intestinal microflora (MIM) in nonalcoholic fatty liver disease (NAFLD). This study intended to investigate the role of NaB in NAFLD and its specific mechanism.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Mice were fed a high‐fat diet (HFD) for 16 weeks to establish the NAFLD mouse model. Then, the mice were intragastrically administered MIM (200 µL/day) or NaB (200 mg/kg/day) by gavage for another 8 weeks. Then, the morphology of liver tissues was observed by H&E staining, and the lipid deposition of liver tissues was examined by oil red O staining. The NAFLD cell model was constructed in AML12 cells by 24 h of stimulation with 0.5 mM free fatty acids. After treatment with 10 mM NaB, AML12 cells were transfected with mimic‐miR‐150 or inhibitor‐miR‐150. qRT‐PCR and Western blotting were employed to measure the contents of IL‐1β, IL‐6, and TNF‐α and the expression of miR‐150 and CXCR4 in liver tissues of mice and in AML12 cells. A luciferase reporter assay was applied to verify the binding relationship between miR‐150 and CXCR4.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The H&E and oil red O staining results showed hepatic steatosis in the liver tissues of HFD‐fed mice. There were elevated contents of TG, TC, HDL‐C, LDL‐C, and fasting blood glucose, enhanced activities of ALT and AST, increased homeostatic model assessment of insulin resistance scores and increased inflammatory responses in the serum of HFD‐fed mice. However, intervention with MIM or NaB reversed the above trends, indicating that MIM or NaB intervention relieved hepatic steatosis in mice. HFD‐fed mice had downregulated expression of miR‐150, while the expression level was upregulated after MIM or NaB treatment. NaB attenuated NAFLD progression by regulating miR‐150. MiR‐150 can negatively target CXCR4.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>NaB mitigates HFD‐induced NAFLD in mice by upregulating miR‐150 expression to downregulate CXCR4.</p></section>

Rebalancing liver-infiltrating CCR3+ and CD206+ monocytes improves diet-induced NAFLD

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes

Elevated CD169 expressing monocyte/macrophage promotes systemic inflammation and disease progression in cirrhosis

Increase of Infiltrating Monocytes in the Livers of Patients with Chronic Liver Diseases

Granulocytic MDSC with Deficient CCR5 Alleviates Lipogenesis and Inflammation in Nonalcoholic Fatty Liver Disease

CCN1 Expression in Hepatocytes Contributes to Macrophage Infiltration in Nonalcoholic Fatty Liver Disease in Mice

Sodium butyrate ameliorates non‐alcoholic fatty liver disease by upregulating miR‐150 to suppress CXCR4 expression

Mesenteric Lymph Node CD4+ T Lymphocytes Migrate to Liver and Contribute to Non-Alcoholic Fatty Liver Disease.

Availability of an inflammatory macrophage niche drives phenotypic and functional alterations in Kupffer cells

Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated Fibrosis

Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy

The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH

Concomitant NAFLD Facilitates Liver Metastases and PD-1-Refractory by Recruiting MDSCs via CXCL5/CXCR2 in Colorectal Cancer

CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice

CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status

Macrophage-specific FGFR1 deletion alleviates high-fat-diet-induced liver inflammation by inhibiting the MAPKs/TNF pathways

Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells

FABP4 in LSECs Promotes CXCL10-mediated Macrophage Recruitment and M1 Polarization During NAFLD Progression.

MERTK+/hi M2c Macrophages Induced by Baicalin Alleviate Non-Alcoholic Fatty Liver Disease

Pharmacological inhibition of the chemokine C‐C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly‐6C+ macrophage infiltration in mice